The emerging role of GLP-1 RA and SGLT-2 inhibitors in preventing T2DM after GDM is examined, with uncertainties persist regarding safety in women of reproductive age, use during lactation, optimal timing, and patient selection.
Yana Vanlaer, Ester Van de Cauter, Nina Embo et al.· BMC Medicine· 0 citations
The primary outcome is a composite of adverse pregnancy outcomes including preterm delivery <37 weeks, LGA [customized percentiles according to Gestation Related Optimal Weight chart (GROW), neonatal hypoglycemia requiring intravenous dextrose, neonatal intensive care unit (NICU) admission > 24 h, and shoulder dystocia...
Ina Geerts, Catherine H. Yu, N. Bochanen et al.· Journal of Clinical Medicine· 0 citations
The incidence of gestational diabetes mellitus (GDM) is rising along with rates of obesity and type 2 diabetes. GDM is associated with an increased risk of various short- and long-term complications for both mother and child, including type 2 diabetes. Managing GDM requires a multidisciplinary approach that includes di...
Ina Geerts, Catherine H. Yu, Nina Embo et al.· BMC Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.